8-K

THERMO FISHER SCIENTIFIC INC. (TMO)

8-K 2024-07-10 For: 2024-07-10
View Original
Added on April 07, 2026

false000009774500000977452023-10-172023-10-170000097745us-gaap:CommonStockMember2023-10-172023-10-170000097745tmo:Zero875NotesDue2031Member2023-10-172023-10-170000097745tmo:Zero125NotesDue2025Member2023-10-172023-10-170000097745tmo:One500NotesDue2039Member2023-10-172023-10-170000097745tmo:Three650NotesDue2034Member2023-10-172023-10-170000097745tmo:Zero750NotesDue2024Member2023-10-172023-10-170000097745tmo:Three200NotesDue2026Member2023-10-172023-10-170000097745tmo:One750NotesDue2027Member2023-10-172023-10-170000097745tmo:One450NotesDue2027Member2023-10-172023-10-170000097745tmo:Two375NotesDue2032Member2023-10-172023-10-170000097745tmo:Two875NotesDue2037Member2023-10-172023-10-170000097745tmo:One875NotesDue2049Member2023-10-172023-10-170000097745tmo:One400NotesDue2026Member2023-10-172023-10-170000097745tmo:One950NotesDue2029Member2023-10-172023-10-170000097745tmo:Two000NotesDue2025Member2023-10-172023-10-170000097745tmo:One375NotesDue2028Member2023-10-172023-10-170000097745tmo:Zero500NotesDue2028Member2023-10-172023-10-17


UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 10, 2024

THERMO FISHER SCIENTIFIC INC.

(Exact name of Registrant as specified in its Charter)

Delaware 1-08002 04-2209186
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer<br> Identification No.)

168 Third Avenue

Waltham, Massachusetts 02451

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (781) 622-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

    \(see General Instruction A.2. below\):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value TMO New York Stock Exchange
0.750% Notes due 2024 TMO 24A New York Stock Exchange
0.125% Notes due 2025 TMO 25B New York Stock Exchange
2.000% Notes due 2025 TMO 25 New York Stock Exchange
3.200% Notes due 2026 TMO 26B New York Stock Exchange
1.400% Notes due 2026 TMO 26A New York Stock Exchange
1.450% Notes due 2027 TMO 27 New York Stock Exchange
1.750% Notes due 2027 TMO 27B New York Stock Exchange
0.500% Notes due 2028 TMO 28A New York Stock Exchange
1.375% Notes due 2028 TMO 28 New York Stock Exchange
1.950% Notes due 2029 TMO 29 New York Stock Exchange
0.875% Notes due 2031 TMO 31 New York Stock Exchange
2.375% Notes due 2032 TMO 32 New York Stock Exchange
3.650% Notes due 2034 TMO 34 New York Stock Exchange
2.875% Notes due 2037 TMO 37 New York Stock Exchange
1.500% Notes due 2039 TMO 39 New York Stock Exchange
1.875% Notes due 2049 TMO 49 New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐   Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 8.01 Other Events.

On July 10, 2024, Thermo Fisher Scientific Inc. (“Thermo Fisher”) issued a press release announcing the expiration and results of the previously announced tender offer by Orion Acquisition AB, a direct, wholly owned subsidiary of Thermo Fisher, to purchase all of the outstanding common shares and all of the outstanding American Depositary Receipts, each representing one common share, of Olink Holding AB (publ).

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press Release, dated July 10, 2024 (filed as Exhibit (a)(5)(W) to the Registrant's Schedule TO-T/A filed July 10, 2024 File No. 005-93360 and incorporated in this document by reference).
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THERMO FISHER SCIENTIFIC INC.
Date: July 10, 2024 By: /s/ Michael A. Boxer
Name: Michael A. Boxer
Title Senior Vice President and General Counsel